Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10025122HBVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS10030429HBVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS10062708HBVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS30083796HIVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS30088840HIVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS20011639HPVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS20059632HPVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS20029777HPVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS20030557HPVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TVIS20029778HPVENSG00000113578.18protein_codingFGF1YesNo2246P05230
TCGA Plot Options
Drug Information
GeneFGF1
DrugBank IDDB01942
Drug NameFormic acid
Target IDBE0000689
UniProt IDP05230
Regulation Type
PubMed IDs17139284; 17016423
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
GroupsExperimental; Investigational
Direct ClassificationCarboxylic acids
SMILES[H]C(O)=O
PathwaysCerivastatin Action Pathway; Desmosterolosis; Pamidronate Action Pathway; Ibandronate Action Pathway; 17-beta Hydroxysteroid Dehydrogenase III Deficiency; DOPA-Responsive Dystonia; Simvastatin Action Pathway; Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2); Smith-Lemli-Opitz Syndrome (SLOS); Pterine Biosynthesis; Lysosomal Acid Lipase Deficiency (Wolman Disease); Steroid Biosynthesis; Hyperphenylalaninemia Due to 6-Pyruvoyltetrahydropterin Synthase Deficiency (ptps); Hypercholesterolemia; Risedronate Action Pathway; Hyperphenylalaniemia Due to Guanosine Triphosphate Cyclohydrolase Deficiency; Mevalonic Aciduria; Tryptophan Metabolism; Rosuvastatin Action Pathway; Alendronate Action Pathway; Zoledronate Action Pathway; Cholesteryl Ester Storage Disease; Androgen and Estrogen Metabolism; Lovastatin Action Pathway; Folate Metabolism; Aromatase Deficiency; Methylenetetrahydrofolate Reductase Deficiency (MTHFRD); Fluvastatin Action Pathway; Atorvastatin Action Pathway; Pravastatin Action Pathway
PharmGKBPA449705
ChEMBLCHEMBL116736